Market Tracker

12/03 11:51am ET

Merck & Co Inc (NYSE:MRK)

73.37
BATS BZX Real-Time Price
As of 11:51am ET
 -0.52 / -0.70%
Today’s Change
68.38
Today|||52-Week Range
91.40
-5.93%
Year-to-Date
Here's Why The New Coronavirus Variant Won't Harm Pfizer's Stock
11:30am / MotleyFool.com - Paid Partner Content
Merck, Novartis in Line for Key FDA Approvals This Month
Dec 02 / GuruFocus News - Paid Partner Content
Aurinia (AUPH) Stock Up on Potential Acquisition Rumors
10:11am / Zacks.com - Paid Partner Content
Merck (MRK) Vaxneuvance sBLA for Pediatrics Gets Priority Review
Dec 02 / Zacks.com - Paid Partner Content
Merck's Selloff Is an Overreaction
9:28am / GuruFocus News - Paid Partner Content
4 Dependable Healthcare Stocks to Buy Hand Over Fist Right Now
Dec 01 / StockNews.com - Paid Partner Content
Pharma Stock Roundup: FDA Panel Vote for MRK COVID Pill, JNJ Omicron Jab Plan
8:47am / Zacks.com - Paid Partner Content
2 Ridiculously Cheap Dividend Stocks To Buy for 2022
Dec 01 / MotleyFool.com - Paid Partner Content
3 Stocks to Buy for the New COVID Variant
Dec 02 / MotleyFool.com - Paid Partner Content
AstraZeneca, Merck's Lynparza sNDA Gets FDA Priority Tag
Dec 01 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close73.89
Today’s open74.17
Day’s range72.80 - 74.24
Volume4,056,743
Average volume (3 months)14,170,617
Market cap$200.0B
Data as of 11:51am ET, 12/03/2021

Growth & Valuation

Earnings growth (last year)-27.21%
Earnings growth (this year)+2.12%
Earnings growth (next 5 years)+12.80%
Revenue growth (last year)+3.06%
P/E ratio22.0
Price/Sales4.33
Price/Book7.91

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk-0.01-0.01%
NVSNovartis0.000.00%
AZNAstraZeneca-0.64-1.17%
ABBVAbbVie+1.30+1.11%
Data as of 11:51am ET, 12/03/2021

Financials

Next reporting dateFebruary 3, 2022
EPS forecast (this quarter)$1.54
Annual revenue (last year)$48.0B
Annual profit (last year)$7.1B
Net profit margin14.72%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
--, --

Forecasts